Tutorials
Bioasis Technologies Inc logo

Bioasis Technologies Inc

$ 0.12 0 (0%) 08:08 PM EST
On watch
P/E:
At Loss
P/B:
0
Market Cap:
$ 9.02M
Enterprise V:
$ 9.81M
Volume:
100.00
Avg Vol (2M):
15.40K
Also Trade In:
Volume:
100.00
Market Cap $:
9.02M
PE Ratio:
At Loss
Avg Vol (2-Month):
15.40K
Enterprise Value $:
9.81M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Bioasis Technologies Inc
NAICS : 325412 SIC : 3741
157 Church Street, 19th Floor, New Haven, CT, USA, 06510
Description
Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier. Its source of revenue involves the research and license revenue.
Name Current Vs Industry Vs History
Cash-To-Debt 0.43
Equity-to-Asset -1.66
Debt-to-Equity -0.83
Debt-to-EBITDA -0.59
Piotroski F-Score 0/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -48.6
Distress
Grey
Safe
Beneish M-Score 357.44
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 71.64
9-Day RSI 61.61
14-Day RSI 53.56
6-1 Month Momentum % -43.98
12-1 Month Momentum % -45

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.38
Quick Ratio 0.38
Cash Ratio 0.25
Days Sales Outstanding 816.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.6

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 145
EV-to-EBIT -4.11
EV-to-EBITDA -4.19
EV-to-Revenue 329.55
EV-to-FCF -3.66
Earnings Yield (Greenblatt) % -24.33

Financials

BIOAF's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:BIOAF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.03
EPS (TTM) ($) -0.034
Beta 0.68
Volatility % 42.76
14-Day RSI 53.56
14-Day ATR ($) 0.005593
20-Day SMA ($) 0.108954
12-1 Month Momentum % -45
52-Week Range ($) 0.0972 - 0.2839
Shares Outstanding (Mil) 79.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bioasis Technologies Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More